Hi Reon1, it would be a smart move to target Pseudomonas infections. This is a particularly nasty bug to knock off. The spin off down the track to target burns could be quite positive as well. What do you think all the delays are due to, in getting larger trials?
Ann: Positive Ph I/II DFI Efficacy Data to Support Site Expansion, page-16
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $85.06M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 29.5¢ | 29.0¢ | $38.76K | 133.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 135000 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 9819 | 2 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |